Herpes

Infectious Disease·MeSH: Herpes Simplex

18 drugs in development·10 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
posoleucel	Kalaris Therapeutics, Inc. (KLRS)

Phase 1(5)

Drug	Company
abi-1179	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-1179 (1179)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
abi-5366	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-5366 (5366)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
BNT163	BioNTech SE (BNTX)

Preclinical(9)

Drug	Company
abi-7272	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-7423 (7423)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
advanced h-plex defense formula 11	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
g103	IMMUNE DESIGN CORP. (IMDZ)
gv2207	GENVEC INC (GNVC)
h-plex defense	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
hsv vaccine	MYMETICS CORP (MYMX)
Non-nucleoside polymerase inhibitor (NNPI program)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
rpi-mn	NUTRA PHARMA CORP (NPHC)

Early Phase 1(1)

Drug	Company
VTP-400	Barinthus Biotherapeutics plc. (BRNS)

Phase 1/Phase 2(1)

Drug	Company
Shingrix	Moderna, Inc. (MRNA)

Phase 4(1)

Drug	Company
mRNA-1468	Moderna, Inc. (MRNA)

BioSniper tracks 18 drugs in development for Herpes across 10 companies.

There are 1 clinical trial targeting Herpes tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.